WuXi AppTec posts record first-quarter revenue on strong global demand
WuXi AppTec, a Chinese pharmaceutical and drug development company, announced record first-quarter revenue for the period ending March 31. The company reported 12.44 billion yuan (US$1.72 billion) in revenue, a 28.81% increase year-on-year, driven by strong global demand from pharmaceutical clients and a substantial order backlog.

Briefing Summary
AI-generatedWuXi AppTec, a Chinese pharmaceutical and drug development company, announced record first-quarter revenue for the period ending March 31. The company reported 12.44 billion yuan (US$1.72 billion) in revenue, a 28.81% increase year-on-year, driven by strong global demand from pharmaceutical clients and a substantial order backlog. Net profit also saw significant growth, rising nearly 27% to 4.65 billion yuan. These financial results surpassed market expectations for both revenue and net profit. The company's performance indicates sustained growth in the global pharmaceutical sector.
Article analysis
Model · rule-basedKey claims
3 extractednet profit climbed nearly 27 per cent to 4.65 billion yuan
28.81 per cent year on year increase in revenue
revenue of 12.44 billion yuan (US$1.72 billion)